Role of Endoscopic Ultrasonography in the Evaluation of Extrahepatic Cholangiocarcinoma
Overview
Affiliations
Cholangiocarcinoma is a malignancy that arises from biliary epithelium and is associated with a poor prognosis. Accurate preopera-tive diagnosis and staging of cholangiocarcinoma continues to remain difficult. Endoscopic retrograde cholangiopancreatography (ERCP) is the most commonly performed procedure for cholangiocarcinoma and can provide a tissue diagnosis through brush cytology of the bile duct. However, the sensitivity of biliary brush cytology to diagnose cholangiocarcinoma may be as low as 30%. Endoscopic ultrasound (EUS) is a diagnostic modality which may overcome the limitations of other imaging and biopsy techniques in this setting. EUS can complement the role of ERCP and provide a tissue diagnosis through fine needle aspiration (FNA) and staging through ultrasound imaging. There is currently a paucity of data about the exact role of EUS for the diagnosis of cholan-giocarcinoma in patients with indeterminate extrahepatic biliary strictures. Although multiple studies have shown that EUS is more accurate than ERCP and radiologic imaging for identifying a biliary mass and diagnosing cholangiocarcinoma, the sensitivities are variable. More importantly, the incidence of false negative results is not negligible, though the specificity is close to 100%. There is also controversy regarding the role of EUS-FNA, since even though this may increase diagnosis, it can also lead to tumor seeding.
Zhang Y, Dong J Biomed Opt Express. 2024; 15(5):3147-3162.
PMID: 38855697 PMC: 11161366. DOI: 10.1364/BOE.519090.
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma.
Dar F, Abbas Z, Ahmed I, Atique M, Aujla U, Azeemuddin M World J Gastroenterol. 2024; 30(9):1018-1042.
PMID: 38577184 PMC: 10989497. DOI: 10.3748/wjg.v30.i9.1018.
Kumar D, Dayal V, Jha S, Jha A, Kumar R Adv Biomed Res. 2024; 13:4.
PMID: 38525391 PMC: 10958731. DOI: 10.4103/abr.abr_220_23.
Updates in Diagnosis and Endoscopic Management of Cholangiocarcinoma.
Caragut R, Ilie M, Cabel T, Gunsahin D, Panaitescu A, Pavel C Diagnostics (Basel). 2024; 14(5).
PMID: 38472961 PMC: 10931405. DOI: 10.3390/diagnostics14050490.
Yang C, Zhou Q, Li M, Xu L, Zeng Y, Liu J BMC Cancer. 2023; 23(1):1089.
PMID: 37950207 PMC: 10636947. DOI: 10.1186/s12885-023-11575-x.